Skip to main content
Feb 5-7, 2027
Miami, FL
Register
Program
Agenda
CE Information
Get to Know LL&M Winter Symposium
Faculty
Hotel & Travel
Pricing
Exhibitors & Sponsors
Press Information
The Official Meeting of
Oncology Learning Network
Agenda
Agenda
Tracks
Leukemia
Lymphoma
CLL
Myeloma
February 5-7, 2027
Register
February 5-7, 2027
Scroll previous
Friday
February 5
Saturday
February 6
Sunday
February 7
Scroll next
Friday February 05, 2027
8:30 AM – 8:40 AM
Welcome
Room
King Ballroom 3
8:40 AM – 9:50 AM
The Evolving Leukemia Landscape: Precision Medicine Takes Hold in AML
Room
King Ballroom 3
Leukemia
8:40 AM – 9:00 AM
Fit or Not: AML Induction Decisions for the Year Ahead
9:00 AM – 9:20 AM
Navigating FLT3 Inhibitors: What's Next in AML?
9:20 AM – 9:40 AM
AML MRD in 2027: How to Use the New ELN Guidelines
9:40 AM – 9:50 AM
Q&A Panel
9:55 AM – 10:55 AM
Breakfast Innovation Theater (non-CME)
Room
Garden Room
10:55 AM – 12:55 PM
The Evolving Leukemia Landscape: Extending Survival and Reducing Burden in MDS, MPN & ALL
Room
King Ballroom 3
Leukemia
10:55 AM – 11:15 AM
MDS in 2027: Treatment Strategies from Supportive Care to Transplant
11:15 AM – 11:35 AM
Myeloproliferative Neoplasms Enter a New Therapeutic Era
11:35 AM – 11:55 AM
Can Older Patients with ALL Move Toward Chemo-Free Care?
11:55 AM – 12:05 PM
Q&A Panel
12:05 PM – 12:55 PM
Navigating the Gray Zones: A Case-Based Panel Discussion in Leukemia
1:00 PM – 2:00 PM
Lunch Innovation Theater (non-CME)
Room
Garden Room
2:00 PM – 2:30 PM
Exhibit Hall
Room
King Ballroom 1-2
2:30 PM – 3:30 PM
Selected Topic in Lymphoma
Room
King Ballroom 3
Lymphoma
3:30 PM – 5:30 PM
The Evolving Lymphoma Landscape: Sequencing Novel Agents Across Indolent Disease and Special Populations
Room
King Ballroom 3
Lymphoma
3:30 PM – 3:50 PM
Follicular Lymphoma in 2027: Sequencing Bispecifics, CAR-T, and the Next Wave of Novel Agents
3:50 PM – 4:10 PM
Reflecting on 2026 and Charting a New Course for Older, Unfit Patients with DLBCL
4:10 PM – 4:30 PM
From Afterthought to Frontier: Sequencing BTK Inhibitors, Bispecifics, and Cellular Therapy in Marginal Zone Lymphoma
4:30 PM – 4:40 PM
Q&A Panel
4:40 PM – 5:30 PM
Translating Evidence Into Action: A Case Discussion Panel in Lymphoma
5:35 PM – 6:35 PM
Dinner Innovation Theater (non-CME)
Room
Garden Room
6:35 PM – 7:20 PM
Exhibit Hall Reception
Room
King Ballroom 1-2
Saturday February 06, 2027
8:30 AM – 8:35 AM
Welcome
Room
King Ballroom 3
8:35 AM – 9:45 AM
The Evolving Lymphoma Landscape: Retiring Old Standards, Writing New Ones
Room
King Ballroom 3
Lymphoma
8:35 AM – 8:55 AM
Hodgkin Lymphoma's New Standard: Immunotherapy Moves to the Frontline
8:55 AM – 9:15 AM
Mantle Cell Lymphoma Turns the Page on Transplant and Chemotherapy
9:15 AM – 9:35 AM
Rewriting the DLBCL Playbook for the Year Ahead
9:35 AM – 9:45 AM
Q&A Panel
9:50 AM – 10:50 AM
Breakfast Innovation Theater (non-CME)
Room
Garden Room
10:50 AM – 11:20 AM
Exhibit Hall
Room
King Ballroom 1-2
11:20 AM – 12:20 PM
Selected Topic in CLL
Room
King Ballroom 3
CLL
12:20 PM – 1:30 PM
The Evolving CLL Landscape: The Chemo-Free Frontline Comes of Age
Room
King Ballroom 3
CLL
12:20 PM – 12:40 PM
The Anti-CD20 Question in BCL2i-Based Fixed-Duration CLL Therapy: New Evidence from 2026
12:40 PM – 1:00 PM
Continuous Therapy in CLL: Weighing the Newest Evidence
1:00 PM – 1:20 PM
New Approval: Sonrotoclax, the Next-Gen BCL2 Inhibitor in CLL
1:20 PM – 1:30 PM
Q&A Panel
1:35 PM – 2:35 PM
Lunch Innovation Theater (non-CME)
Room
Garden Room
2:50 PM – 4:50 PM
The Evolving CLL Landscape: The Next Wave of Therapy for Relapsed and High-Risk Disease
Room
King Ballroom 3
CLL
2:50 PM – 3:10 PM
Bispecific Antibodies and CAR-T in CLL: Positioning Two Emerging Immunotherapies
3:10 PM – 3:30 PM
Richter Transformation in 2027: Any Updates?
3:30 PM – 3:50 PM
BTK Degraders in CLL: Where Do We Currently Stand?
3:50 PM – 4:00 PM
Q&A Panel
4:00 PM – 4:50 PM
Clinical Crossroads: A Case Discussion Panel in CLL
4:55 PM – 5:55 PM
Dinner Innovation Theater (non-CME)
Room
Garden Room
5:55 PM – 7:25 PM
Outdoor Welcome Reception
Room
Cascata Pool
Sunday February 07, 2027
8:30 AM – 8:35 AM
Welcome
Room
King Ballroom 3
8:35 AM – 9:35 AM
Specialty Session
Room
King Ballroom 3
9:40 AM – 10:40 AM
Breakfast Innovation Theater (non-CME)
Room
Garden Room
10:40 AM – 11:10 AM
Exhibit Hall
Room
King Ballroom 1-2
11:10 AM – 12:20 PM
The Evolving Myeloma Landscape: Precision Monitoring from Smoldering Disease to MRD
Room
King Ballroom 3
Myeloma
11:10 AM – 11:30 AM
Smoldering Myeloma in 2027: Latest Clinical Updates on Risk Stratification and Early Intervention
11:30 AM – 11:50 AM
Beyond the Bone Marrow: Liquid Biopsies and Advanced Imaging for Disease Monitoring
11:50 AM – 12:10 PM
MRD in 2027: From Clinical Trial Endpoint to Clinical Decision Tool
12:10 PM – 12:20 PM
Q&A Panel
12:20 PM – 1:20 PM
Selected Topic in Myeloma
Room
King Ballroom 3
Myeloma
1:25 PM – 2:25 PM
Lunch Innovation Theater (non-CME)
Room
Garden Room
2:25 PM – 4:25 PM
The Evolving Myeloma Landscape: Expanding the Cellular and Immunotherapy Toolbox
Room
King Ballroom 3
Myeloma
2:25 PM – 2:45 PM
Bispecific and Trispecific Antibodies: Expanding the Immunotherapy Toolbox in Myeloma
2:45 PM – 3:05 PM
CAR-T Cell Therapy in 2027: Optimizing Outcomes Across the Disease Continuum
3:05 PM – 3:25 PM
Future in cellular therapy: non BCMA targets and In Vivo CAR-T: Engineering Cellular Therapy Without Manufacturing
3:25 PM – 3:35 PM
Q&A Panel
3:35 PM – 4:25 PM
From Trial to Treatment: A Case Discussion Panel in Myeloma
Back to top
